Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Alexandra Vaz, Mariana Roldão Santos, Luther Gwaza, Elena Mezquita González, Magdalena Pajewska Lewandowska, Samvel Azatyan & Agnès Saint-Raymond. (2022) WHO collaborative registration procedure using stringent regulatory authorities’ medicine evaluation: reliance in action?. Expert Review of Clinical Pharmacology 15:1, pages 11-17.
Read now
Read now
Articles from other publishers (9)
Nevena Miletic, Sarah Adam, Jacqueline Acquah, Zainab Aziz, Angelika Joos & John M. Mwangi. (2023) What makes joint assessment procedures attractive to the innovative industry: successes, challenges, and proposed improvements. Frontiers in Medicine 10.
Crossref
Crossref
Lisa Gieber, Vincent Muturi-Kioi, Shelly Malhotra & Ayesha Sitlani. (2023) Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond. Pharmaceutical Medicine 37:3, pages 203-214.
Crossref
Crossref
Cheng Zhang, Guoming Chen, Guoyi Tang, Xiaoyu Xu, Zixin Feng, Yuanjun Lu, Yau-Tuen Chan, Junyu Wu, Yuanyuan Chen, Lin Xu, Qing Ren, Hongchao Yuan, Dong-Hua Yang, Zhe-Sheng Chen, Ning Wang & Yibin Feng. (2023) Multi-component Chinese medicine formulas for drug discovery: State of the art and future perspectives. Acta Materia Medica 2:1.
Crossref
Crossref
Jaime Algorta, Alejandro Krolewiecki, Filipe Pinto, Silvia Gold & Jose Muñoz. (2022) Pharmacokinetic Characterization and Comparative Bioavailability of an Innovative Orodispersible Fixed-Dose Combination of Ivermectin and Albendazole: A Single Dose, Open Label, Sequence Randomized, Crossover Clinical Trial in Healthy Volunteers. Frontiers in Pharmacology 13.
Crossref
Crossref
Bakani Mark Ncube, Admire Dube & Kim Ward. (2022) Medicines Regulatory Science Expertise in Africa: Workforce Capacity Development and Harmonisation Activities Towards the Establishment of the African Medicines Agency. Pharmaceutical Medicine 36:2, pages 83-97.
Crossref
Crossref
Boitumelo Semete‐Makokotlela, Gugu N. Mahlangu, David Mukanga, Delese Mimi Darko, Peter Stonier, Luther Gwaza, Portia Nkambule, Precious Matsoso, Regine Lehnert, Bernd Rosenkranz & Goonaseelan (Colin) Pillai. (2021) Needs‐driven talent and competency development for the next generation of regulatory scientists in Africa. British Journal of Clinical Pharmacology 88:2, pages 579-586.
Crossref
Crossref
William A. Gahl, Durhane Wong-Rieger, Virginie Hivert, Rachel Yang, Galliano Zanello & Stephen Groft. (2021) Essential list of medicinal products for rare diseases: recommendations from the IRDiRC Rare Disease Treatment Access Working Group. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Katrina Perehudoff, Carlos Durán, Ivan Demchenko, Valentina Mazzanti, Pramiti Parwani, Fatima Suleman & Anniek de Ruijter. (2021) Impact of the European Union on access to medicines in low- and middle-income countries: A scoping review. The Lancet Regional Health - Europe 9, pages 100219.
Crossref
Crossref
Carlos E. Durán, Martín Cañás, Martín Urtasun, Monique Elseviers, Robert Vander Stichele & Thierry Christiaens. (2021) Potential negative impact of reputed regulators’ decisions on the approval status of new cancer drugs in Latin American countries: A descriptive analysis. PLOS ONE 16:7, pages e0254585.
Crossref
Crossref